EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD).

Area of Science:

• Pulmonology
• Respiratory Medicine
• Clinical Epidemiology

Background:

• Chronic Obstructive Pulmonary Disease (COPD) presents significant morbidity and mortality.
• The natural history of COPD is poorly understood due to imprecise early detection and reliance on FEV1 for monitoring.
• Current medical literature often uses 'EARLY COPD' and 'MILD COPD' interchangeably, causing definitional ambiguity.

Purpose of the Study:

• To clarify the definitions of EARLY COPD and MILD COPD.
• To provide a synopsis of the natural history of COPD.
• To propose distinct criteria for staging early and mild COPD.

Main Methods:

• Review of existing medical literature on COPD natural history and staging.
• Analysis of the utility of FEV1 in monitoring COPD progression.
• Discussion of the limitations of spirometry in fully assessing COPD clinical status.

Main Results:

• Recommends defining EARLY COPD as the pre-clinical stage (Stage 0).
• Proposes MILD COPD be defined by spirometry confirmation with FEV1 > 80% predicted (Stage I).
• Highlights that spirometry alone is insufficient to fully characterize the clinical status of patients with MILD COPD.

Conclusions:

• There is an urgent need for biomarkers to accurately detect the onset of COPD.
• Biomarkers are essential for more precise tracking of COPD's natural history beyond FEV1 measurements.
• Improved staging and monitoring are critical for managing this complex disease.